Recognition-Motif Screening
Identify degron-like or other compact sequence features recognized by an E3/DUB component.
Creative Biolabs supports phage display discovery of E3 ligase and DUB substrates with motif screening, enzyme-dependent validation, and cellular follow-up.
E3 ligase and deubiquitinase projects need to distinguish sequence recognition from true substrate processing. Creative Biolabs uses phage display protein interaction mapping to screen peptide, cDNA, or protein-fragment libraries against relevant E3/DUB recognition components, generating enriched motifs or protein-derived candidates for independent binding and, when the project requires it, enzyme-dependent validation.
For E3 programs, the key handoff is from recognition to ubiquitination in a reconstituted ligase context that reflects the mechanistic question. For DUB programs, the critical step is to show catalytic deubiquitination under a relevant ubiquitin-chain or substrate state. Cellular ubiquitin-state and protein-behavior readouts can be considered later when they are within scope and necessary for physiological interpretation.
Peptide libraries are well suited to degron-like or compact recognition motifs that can connect to binding motif identification, whereas protein-derived fragments can nominate broader candidate substrates or regions that may later be refined through interaction domain mapping. The intended evidence level—binder, biochemical substrate candidate, or cellularly supported relationship—should be defined before library selection.
Identify degron-like or other compact sequence features recognized by an E3/DUB component.
Recover cDNA or protein-fragment candidates for broader substrate or interaction hypotheses.
Separate direct recognition from E3-dependent ubiquitination or DUB-dependent deubiquitination when substrate status matters.
Add cellular ubiquitin-state or protein-behavior follow-up only when included in scope and needed for physiological interpretation.
| E3 Ligase Projects | DUB Projects |
|---|---|
| Discovery focus:recognition motifs, degron-like sequences, or protein-derived candidates that interact with the relevant recognition machinery. | Discovery focus:motifs or protein-derived candidates that bind a catalytic or recognition domain in the relevant DUB context. |
| Critical validation:demonstrate E3-dependent ubiquitination in the appropriate E1/E2/E3 context with recognition/catalytic controls. | Critical validation:demonstrate catalytic deubiquitination in the relevant ubiquitin state with catalytic-dead or other specificity controls. |
| When physiological context is needed and separately scoped, connect cellular ubiquitin state, stability, or behavior to the intended E3 machinery. | If cellular interpretation is required and separately scoped, test whether ubiquitin state or protein behavior changes with the intended DUB activity. |
| After a binder is confirmed, recognition-site mapping can use domain/peptide constructs, competition, and targeted mutation. | Once direct recognition is established, DUB-contact mapping can use focused constructs, competition, or targeted mutation when localization is the next question. |
Many E3 ligases recognize substrates through substrate receptors, adaptors, or multi-subunit complexes rather than through a catalytic component alone. DUB specificity can also depend on accessory domains, ubiquitin-chain linkage, chain length, substrate conformation, and localization. We therefore choose the bait that has a defensible relationship to recognition and explicitly note which parts of the native complex are absent from the screen.
Phosphorylation, hydroxylation, cleavage, ligand binding, or another state can create or expose a recognition element that an unmodified displayed peptide may miss.
Substrate recognition may depend on receptors, adaptors, or multi-subunit assembly rather than an isolated catalytic component.
DUB processing can depend on ubiquitin linkage, chain length, substrate conformation, and accessory domains; binding alone does not show catalytic processing.
Failure to recover a candidate is not definitive when the required PTM, cofactor, conformation, or assembled complex is absent from the screen.
| Library Route | Best Suited For | Interpretation Boundary |
|---|---|---|
| Peptide library | Compact recognition motifs, degron-like sequences, or competitive elements | Fast synthesis and focused follow-up, but limited native protein context. |
| cDNA / protein-fragment library | Protein-derived interaction regions or candidate substrate nomination | More sequence context, with reading-frame, folding, expression, and display bias. |
| NGS sequence-family analysis | Recurring motif families and differential enrichment across control baits | Prioritizes candidates; abundance alone does not establish substrate status. |
Document the E3/DUB component, substrate receptor or adaptor, catalytic state, relevant complex members, known substrates/motifs, PTM dependencies, desired evidence level, library route, and control baits.
Use positive selection and depletion to generate enriched sequence families, then assess clone sequences or NGS data and map candidates to motifs or parent proteins.
Test prioritized peptides, fragments, or full-length candidates independently to determine whether recognition persists without phage-particle avidity.
Evaluate E3 candidates in the relevant E1/E2/E3 context and DUB candidates with catalytic-dead or specificity controls, adding motif transplantation, site-directed mutation, competition, or domain constructs when required.
Measure cellular ubiquitin state, protein stability, localization, or pathway behavior only when those readouts are needed for physiological interpretation.
For an E3 ligase, a strong biochemical substrate result should depend on the relevant active ligase machinery rather than only on binding to one component. For a DUB, catalytic-dead controls help distinguish a protein that associates with the enzyme from one whose ubiquitin state is directly altered by DUB activity. The exact assay components depend on the ligase or DUB system, chain type, and mechanistic question.
Cellular protein abundance alone can be misleading because transcription, translation, trafficking, degradation pathways, and indirect signaling can all alter steady-state levels. When cellular relevance is part of the goal, we prefer evidence that connects the candidate to the intended E3/DUB, such as changes in ubiquitination pattern, stability, or behavior that are dependent on the enzyme or recognition machinery.
| Observation | What It Supports | What Is Still Needed for Stronger Substrate Status |
|---|---|---|
| Phage enrichment | Candidate motif or protein-derived sequence | Independent binding confirmation. |
| Independent binding | Direct recognition under the tested conditions | Enzyme-dependent modification/de-modification. |
| In vitro ubiquitination | Biochemical E3-dependent modification | Cellular relevance when physiological substrate status is claimed. |
| In vitro deubiquitination | Biochemical DUB activity on the tested ubiquitin state | Cellular ubiquitin-state or protein-behavior evidence. |
| Cellular stability/abundance change | Context-specific candidate behavior | Evidence that the change is causally linked to the intended ubiquitin pathway. |
Candidates should be labeled by the evidence actually generated so a binder, recognition motif, biochemical substrate candidate, and cellularly supported substrate are not presented as equivalent.
Guo and colleagues reported a live phage display strategy for screening substrates of the E3 ligase MDM2. The study moved beyond binding enrichment by testing selected candidates in ubiquitination assays: among the tested proteins, multiple candidates showed MDM2-dependent ubiquitination, and several novel candidates were further supported in ex vivo experiments. The work provides a direct example of using phage display to generate substrate candidates and then requiring enzyme-dependent evidence before strengthening the substrate claim.
This published study illustrated that: selection identifies candidates; independent interaction and enzyme assays test whether recognition is connected to ubiquitin chemistry; cellular work is reserved for stronger physiological interpretation. That sequence prevents a binding motif from being mistaken for a validated substrate.
Share your E3 ligase or DUB, recognition/catalytic domain, complex composition, cofactors, known motifs or substrates, desired library, PTM dependencies, control baits, and biochemical/cellular evidence requirements. Creative Biolabs can help you build a research-use discovery program that keeps motif recognition, binding, enzyme activity, and substrate status clearly separated.
Discuss Your Project
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
